Michael Ilan Management & Investments

Portfolio · 2

Velox

Direct-to-shape Digital Decoration

1 round $32.0M committed Latest: 2018-11

BioSight

Therapeutics for Oncology and Hematological Disorders

1 round $13.0M committed Latest: 2016-05

Investment activity

1 portfolio exit on record.

Q&A

What is a notable recent exit for Michael Ilan Management & Investments?

In October 2023, BioSight, a therapeutics company for oncology and hematological disorders, was acquired by Ayala Pharmaceuticals. Michael Ilan Management & Investments was an investor in BioSight.

Which sectors does Michael Ilan Management & Investments focus on?

Michael Ilan Management & Investments has portfolio companies in Health Tech & Life Sciences and Industrial Technologies.

Can you name some of Michael Ilan Management & Investments' portfolio companies?

Michael Ilan Management & Investments' portfolio includes BioSight, which focuses on therapeutics for oncology, and Velox, which specializes in direct-to-shape digital decoration.

What is the investment stage focus of Michael Ilan Management & Investments?

According to startupim data, Michael Ilan Management & Investments has participated in A Round and B Round funding stages.

What was Michael Ilan Management & Investments' most recent investment activity?

Michael Ilan Management & Investments made an investment in November 2018.

Which portfolio company of Michael Ilan Management & Investments has raised a significant amount of capital?

Velox, a portfolio company of Michael Ilan Management & Investments, has raised $109.5M across its funding rounds.

What is the total capital raised by BioSight, a former portfolio company of Michael Ilan Management & Investments?

BioSight, which was acquired in October 2023, raised $62.5M prior to its acquisition.